To the Editor In the recent article by Guo et al, the authors report outcomes of 4 age-defined cohorts receiving antileukemia drugs and a microtransplant. There are no controls not receiving a microtransplant, so it is impossible to know what impact the microtransplant, if any, had on the reported outcomes. Moreover, there is no attempt to account for obvious selection biases operating in the older subject cohorts. An explanation seems warranted.
https://ift.tt/2EGHtRJ
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Abstract The changes of dissolved organic matter (DOM) components during stabilization process play significant effects on its redox prope...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου